| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |